Nutrient transporters: connecting cancer metabolism to therapeutic opportunities

被引:0
|
作者
Zeribe Chike Nwosu
Mun Gu Song
Marina Pasca di Magliano
Costas A. Lyssiotis
Sung Eun Kim
机构
[1] University of Michigan,Department of Molecular & Integrative Physiology
[2] University of Michigan,Rogel Cancer Center
[3] Korea University,Department of Biosystems and Biomedical Sciences, College of Health Sciences
[4] Korea University,Department of Integrated Biomedical and Life Sciences, College of Health Sciences
[5] University of Michigan,Department of Surgery
[6] University of Michigan,Department of Internal Medicine, Division of Gastroenterology
来源
Oncogene | 2023年 / 42卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cancer cells rely on certain extracellular nutrients to sustain their metabolism and growth. Solute carrier (SLC) transporters enable cells to acquire extracellular nutrients or shuttle intracellular nutrients across organelles. However, the function of many SLC transporters in cancer is unknown. Determining the key SLC transporters promoting cancer growth could reveal important therapeutic opportunities. Here we summarize recent findings and knowledge gaps on SLC transporters in cancer. We highlight existing inhibitors for studying these transporters, clinical trials on treating cancer by blocking transporters, and compensatory transporters used by cancer cells to evade treatment. We propose targeting transporters simultaneously or in combination with targeted therapy or immunotherapy as alternative strategies for effective cancer therapy.
引用
收藏
页码:711 / 724
页数:13
相关论文
共 50 条
  • [41] Dysregulated cellular metabolism in atherosclerosis: mediators and therapeutic opportunities
    Stroope, Chad
    Nettersheim, Felix Sebastian
    Coon, Brian
    Finney, Alexandra C.
    Schwartz, Martin A.
    Ley, Klaus
    Rom, Oren
    Yurdagul, Arif
    NATURE METABOLISM, 2024, 6 (04) : 617 - 638
  • [42] Senescence and cancer - role and therapeutic opportunities
    Schmitt, Clemens A.
    Wang, Boshi
    Demaria, Marco
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (10) : 619 - 636
  • [43] Converting cancer mutations into therapeutic opportunities
    O'Brien, Tom
    Stokoe, David
    EMBO MOLECULAR MEDICINE, 2009, 1 (6-7) : 297 - 299
  • [44] Senescence and cancer — role and therapeutic opportunities
    Clemens A. Schmitt
    Boshi Wang
    Marco Demaria
    Nature Reviews Clinical Oncology, 2022, 19 : 619 - 636
  • [45] THE ORIGIN OF CHILDHOOD CANCER & THERAPEUTIC OPPORTUNITIES
    Behjati, Sam
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S2 - S2
  • [46] Yeast nutrient transporters
    Horak, J
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON BIOMEMBRANES, 1997, 1331 (01): : 41 - 79
  • [47] Aberrant Sialylation in Cancer: Therapeutic Opportunities
    Munkley, Jennifer
    CANCERS, 2022, 14 (17)
  • [48] Nutrient metabolism in colonic mucosa and cancer
    Aujla, P
    Eggo, M
    Langman, M
    Singh, S
    GASTROENTEROLOGY, 2001, 120 (05) : A674 - A674
  • [49] Oligopeptide Transporters as Putative Therapeutic Targets for Cancer Cells
    Randall J. Mrsny
    Pharmaceutical Research, 1998, 15 : 816 - 818
  • [50] Lactate transporters as therapeutic targets in cancer and inflammatory diseases
    Pucino, Valentina
    Cucchi, Danilo
    Mauro, Claudio
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2018, 22 (09) : 735 - 743